药物对比
Dapagliflozin vs Glyburide
Dapagliflozin 与 Glyburide 对比：治疗糖尿病的SGLT2与磺脲类（SU）。减重和心脏获益 versus 低费用和低血糖风险。哪个更适合您？
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes on older sulfonylureas considering a switch to an SGLT2 inhibitor for added heart and kidney benefits.
结论
Dapagliflozin generally offers more comprehensive benefits than glyburide for most type 2 diabetes patients, particularly those with heart or kidney issues.
全部药物对比